HLS Therapeutics Stock Forward View - Daily Balance Of Power
| HLS Stock | CAD 4.50 0.01 0.22% |
HLS Stock outlook is based on your current time horizon. Although HLS Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of HLS Therapeutics' systematic risk associated with finding meaningful patterns of HLS Therapeutics fundamentals over time.
As of today the relative strength index (rsi) of HLS Therapeutics' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.05) | EPS Estimate Current Year (0.42) | EPS Estimate Next Year (0.22) | Wall Street Target Price 7.7247 | EPS Estimate Current Quarter (0.07) |
Using HLS Therapeutics hype-based prediction, you can estimate the value of HLS Therapeutics from the perspective of HLS Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
HLS Therapeutics after-hype prediction price | CAD 4.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
HLS |
HLS Therapeutics Additional Predictive Modules
Most predictive techniques to examine HLS price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for HLS using various technical indicators. When you analyze HLS charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| 0.8333 | 0.0435 |
| Check HLS Therapeutics Volatility | Backtest HLS Therapeutics | Information Ratio |
HLS Therapeutics Trading Date Momentum
| On February 04 2026 HLS Therapeutics was traded for 4.50 at the closing time. The maximum traded price for the trading interval was 4.50 and the lowest daily price was 4.27 . The daily volume was recorded at 3.8 K. The volume of trading on 4th of February 2026 did not cause price change. The trading delta at closing time to the closing price today is 4.67% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare HLS Therapeutics to competition |
Other Forecasting Options for HLS Therapeutics
For every potential investor in HLS, whether a beginner or expert, HLS Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. HLS Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in HLS. Basic forecasting techniques help filter out the noise by identifying HLS Therapeutics' price trends.HLS Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HLS Therapeutics stock to make a market-neutral strategy. Peer analysis of HLS Therapeutics could also be used in its relative valuation, which is a method of valuing HLS Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
HLS Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how HLS Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HLS Therapeutics shares will generate the highest return on investment. By undertsting and applying HLS Therapeutics stock market strength indicators, traders can identify HLS Therapeutics entry and exit signals to maximize returns.
HLS Therapeutics Risk Indicators
The analysis of HLS Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in HLS Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hls stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.06 | |||
| Standard Deviation | 1.57 | |||
| Variance | 2.46 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for HLS Therapeutics
The number of cover stories for HLS Therapeutics depends on current market conditions and HLS Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that HLS Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about HLS Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
HLS Therapeutics Short Properties
HLS Therapeutics' future price predictability will typically decrease when HLS Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of HLS Therapeutics often depends not only on the future outlook of the potential HLS Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HLS Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.8 M | |
| Cash And Short Term Investments | 17.5 M |
Other Information on Investing in HLS Stock
HLS Therapeutics financial ratios help investors to determine whether HLS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.